mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.002 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.002 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |